Islamabad [Pakistan], November 11 (ANI): Pakistan on Thursday approved Chinese COVID-19 vaccines Sinopharm and Sinovac for children above 12 with an efficacy rate of 79 per cent and 51 per cent respectively.

The National Command and Operation Centre (NCOC), in a tweet, said the forum's expert committee had approved administering the vaccines -- in addition to Pfizer -- to the age group from November 15 onwards, reported Geo News.

Also Read | Thomas West, US Special Representative to Afghanistan, to Meet Taliban Foreign Minister Amir Khan Motaqi in Pakistan.

So far, the country has administered more than 5.5 million vaccines to students between the ages of 12-18 years.

Pakistan administered 1.7 million coronavirus vaccine doses on November 9, which was its highest daily tally to date, reported Geo News.

Also Read | Yemen’s Houthi Militia Claim Responsibility for Ballistic Missile Attack on Saudi Military Base.

Meanwhile, in the last 24 hours, the country has reported 637 fresh coronavirus cases and nine deaths, as per NCOC's daily stats.

The total tally of COVID-19 cases has reached 1.27 million, while the death toll has bumped to 28,575, the NCOC website showed.

The NCOC had emphasised stepping up the administration of the second dose of COVID-19 vaccine to eligible individuals to sufficiently raise the immunity level of the population for long-term dividends, reported Geo News. (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)